FDA clears the way for IM fixation in Extremities

See my interview with Wade Fallin HERE

FDA CLEARS WAY FOR INTRAMEDULLARY FIXATION FOR EXTREMITIES  (Orthopedics This Week) Wade Fallin, the CEO of IntraFuse, says intramedullary fixation is the standard-of-care today for most fractures of the large, long bones of the body due to superior clinical outcomes versus plating systems, yet plating systems are still the standard-of-care for the smaller, long bones of the extremities." But with the FDA 510(k) clearance of Logan, Utah-based IntraFuse's FlexThread Fibula Pin System, the options for surgeons are widening. Percutaneous Fixation The FlexThread provides percutaneous fixation of distal fibula fractures, primarily Danis-Weber B type fractures, or trans-syndesmotic fractures. The company said on November 1, 2017 that the system's "simple and elegant design is easy to insert and cost competitive with today's standard-of-care internal fixation hardware." The distal end of the implant is a flexible, intramedullary screw and the proximal end is a rigid, high-strength intramedullary rod. Upon insertion of the implant into the fibula, the rigid rod portion of the implant spans and supports the fracture and the flexible screw portion bend...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top